Recent Updates
Recently added Catalysts
WST Positive Sentiment

West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...

Key Takeaway: West Pharmaceutical Services, Inc. (NYSE: WST) announced its participation in the CPHI Worldwide Conference in Milan, Italy, where it will showcase its expertise in packaging and containment solutions for injectable drug administration. The company will focus on the revisions to EU GMP Annex 1, emphasizing the importance of quality control in drug manufacturing. Additionally, West is a finalist for a prestigious CPHI Award, highlighting its commitment to philanthropic initiatives. The awards ceremony will take place on October 8th.
Price reaction · baseline $296.5 (2024-10-04 close) · 2 other WST headline(s) in the window, move may be shared
day 0 close · peak
-2.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation at a significant industry event, CPHI Worldwide.
  • Highlighting innovations in drug packaging and containment strategies.
  • Recognition as a finalist for a CPHI Award for community involvement.

Full Press Release Details

EXTON, Pa. , Oct. 7 , 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment.
This year, West will highlight its industry expertise through a technical-focused presentation:
"The revisions to EU GMP Annex 1 represent a significant shift in drug manufacturing with over 30 references to primary packaging alone," said Cindy Reiss-Clark , Chief Commercial Officer at West. "At West, we know a drug manufacturer's contamination control strategy is only as strong as its weakest link, making the quality and control of materials from third party suppliers' critical factors to their process."
West is also a finalist for a CPHI Award in the "Heart of Pharma" category for its partnership with Fox Chase Cancer Center. This award recognizes companies, individuals and initiatives which nurture philanthropic, ethical and community-based ventures. Winners will be announced during the awards ceremony on the opening night of CPHI on October 8 .
For more information about West, please visit our website: www.westpharma.com .
For more information about CPHI Worldwide , please visit: CPHI Milan
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in Exton, Pennsylvania , West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com .

Frequently Asked Questions

What are West Pharmaceutical Services known for?

West Pharmaceutical Services specializes in innovative solutions for injectable drug administration.

What event is West participating in 2024?

West is participating in CPHI Worldwide in Milan, Italy to showcase industry expertise.

Why is West's presentation at CPHI significant?

It addresses significant shifts in drug manufacturing and packaging quality control.

What recognition is West nominated for at CPHI?

West is a finalist for the CPHI Award in the 'Heart of Pharma' category.

Where is West Pharmaceutical Services headquartered?

West is headquartered in Exton, Pennsylvania.

Last updated: Oct 7, 2024